MREO
Price
$0.41
Change
-$0.01 (-2.38%)
Updated
Feb 4 closing price
Capitalization
66.52M
55 days until earnings call
Intraday BUY SELL Signals
VTGN
Price
$0.53
Change
-$0.01 (-1.85%)
Updated
Feb 4 closing price
Capitalization
20.78M
Intraday BUY SELL Signals
Interact to see
Advertisement

MREO vs VTGN

Header iconMREO vs VTGN Comparison
Open Charts MREO vs VTGNBanner chart's image
Mereo BioPharma Group
Price$0.41
Change-$0.01 (-2.38%)
Volume$4.74M
Capitalization66.52M
VistaGen Therapeutics
Price$0.53
Change-$0.01 (-1.85%)
Volume$849.43K
Capitalization20.78M
MREO vs VTGN Comparison Chart in %
MREO
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MREO vs. VTGN commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MREO is a StrongBuy and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (MREO: $0.41 vs. VTGN: $0.53)
Brand notoriety: MREO and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MREO: 24% vs. VTGN: 25%
Market capitalization -- MREO: $66.52M vs. VTGN: $20.78M
MREO [@Biotechnology] is valued at $66.52M. VTGN’s [@Biotechnology] market capitalization is $20.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MREO’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 1 green FA rating(s).

  • MREO’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 1 green, 4 red.
According to our system of comparison, MREO is a better buy in the long-term than VTGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MREO’s TA Score shows that 5 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • MREO’s TA Score: 5 bullish, 4 bearish.
  • VTGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MREO is a better buy in the short-term than VTGN.

Price Growth

MREO (@Biotechnology) experienced а -8.69% price change this week, while VTGN (@Biotechnology) price change was -10.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

MREO is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MREO($66.5M) has a higher market cap than VTGN($20.8M). MREO YTD gains are higher at: -1.608 vs. VTGN (-20.502). MREO has higher annual earnings (EBITDA): -40.14M vs. VTGN (-64.79M). VTGN has more cash in the bank: 77.2M vs. MREO (48.7M). MREO has less debt than VTGN: MREO (397K) vs VTGN (1.87M). VTGN has higher revenues than MREO: VTGN (721K) vs MREO (500K).
MREOVTGNMREO / VTGN
Capitalization66.5M20.8M320%
EBITDA-40.14M-64.79M62%
Gain YTD-1.608-20.5028%
P/E RatioN/AN/A-
Revenue500K721K69%
Total Cash48.7M77.2M63%
Total Debt397K1.87M21%
FUNDAMENTALS RATINGS
MREO vs VTGN: Fundamental Ratings
MREO
VTGN
OUTLOOK RATING
1..100
7681
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
15
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9697
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
47n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (15) in the Biotechnology industry is somewhat better than the same rating for MREO (58) in the null industry. This means that VTGN’s stock grew somewhat faster than MREO’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MREO (100) in the null industry. This means that VTGN’s stock grew similarly to MREO’s over the last 12 months.

VTGN's SMR Rating (98) in the Biotechnology industry is in the same range as MREO (98) in the null industry. This means that VTGN’s stock grew similarly to MREO’s over the last 12 months.

MREO's Price Growth Rating (96) in the null industry is in the same range as VTGN (97) in the Biotechnology industry. This means that MREO’s stock grew similarly to VTGN’s over the last 12 months.

MREO's P/E Growth Rating (1) in the null industry is significantly better than the same rating for VTGN (100) in the Biotechnology industry. This means that MREO’s stock grew significantly faster than VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MREOVTGN
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 23 days ago
81%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
MREO
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LGPS0.830.04
+5.25%
LogProstyle Inc
GHC1160.183.23
+0.28%
Graham Holdings Company
NVCT8.46-0.02
-0.24%
Nuvectis Pharma
SE106.26-1.94
-1.79%
Sea Limited
ORIC10.61-0.39
-3.55%
Oric Pharmaceuticals

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been closely correlated with VTGN. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if MREO jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
-2.73%
VTGN - MREO
87%
Closely correlated
-3.20%
RZLT - MREO
82%
Closely correlated
-7.62%
CALC - MREO
80%
Closely correlated
+8.37%
BCAB - MREO
80%
Closely correlated
+11.06%
GNTA - MREO
77%
Closely correlated
-1.27%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been closely correlated with QNCX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if VTGN jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-3.20%
QNCX - VTGN
92%
Closely correlated
+9.28%
RZLT - VTGN
87%
Closely correlated
-7.62%
GNTA - VTGN
83%
Closely correlated
-1.27%
IMRN - VTGN
79%
Closely correlated
-3.43%
BDRX - VTGN
79%
Closely correlated
-11.04%
More